Clinical Trials Directory

Trials / Completed

CompletedNCT00848003

Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Adults on Antibiotics

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Georgetown University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

We believe a readily available drink containing a high dose of probiotics has the potential to improve compliance through many of these mechanisms. This product also has the potential to positively impact the health of children and adults around the world, as yogurt will likely be more appealing to both children and their parents for long term consumption than pharmaceutical-like preparations. In addition to the benefits associated with the consumption of probiotics, there is an increased health benefit from consuming yogurt, a nutrient dense food. More specifically, the rationale for this Phase I study is to determine safety of our drink and comply with the FDA's recommendations pertaining to an IND application, we will conduct a phase I safety study. We hypothesize that BB-12 is safe in healthy adults ages 18 and over.

Conditions

Interventions

TypeNameDescription
DRUGBifidobacterium animalis subsp. lactis strain BB-12Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12 (BB-12) probiotic supplemented yogurt, 4 ounces taken orally for 10 days
DRUGPlaceboStrawberry flavored yogurt

Timeline

Start date
2009-10-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2009-02-20
Last updated
2013-05-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00848003. Inclusion in this directory is not an endorsement.

Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Adults on Antibiotics (NCT00848003) · Clinical Trials Directory